Endocrine Abstracts

Introduction: The management of diabetes goes through the education but also the management of acute and chronic complications. Among the complications, erectile dysfunction are too often forgotten as they actually affect the quality of life. The repercussions of this complication incite the clinician to look for it among the other complications of diabetes. The aim of our study is to evaluate the prevalence of erectile dysfunction in a diabetic population and to evaluate its clinical severity.

Patients and methods: This is a prospective study of diabetic patients hospitalized for diabetes from January 2017 to April 2017. The types of diabetes included were type 1 and type 2 diabetes. Diagnosis of dysfunction Erectile was done at the time of hospitalization and the degree of severity was assessed by Urological Score IIEF5 Simplified International Index of Erectile Function interpreted as: Severe erectile dysfunction (score of 5–10), moderate (11–15), mild (16–20), normal erectile function (21–25) and uninterpretable (1–4).

Results: There were 114 patients with a mean age of 53.77±10.8 years. The family history was type 2 diabetes in 78.9%, hyperrtension in 43.9%, and ischemic stroke in 16.1% of cases. Of the patients, 30.1% were hypertensive, 32.5% were dyslipidemic all under statins, 71.9% were smokers. Type 2 was predominant in patients in 91.2%. Treatment of diabetes was insulin-only in 48.1% of cases, oral antidiabetic alone in 18.4% and 32.5% in combination. Degenerative complications were present in 51.4%, with diabetic retinopathy in 51.4% of cases, diabetic neuropathy in 44.2% of cases and diabetic nephropathy in 18.2% of cases. The mean BMI of patients was =26±5.6 kg/m² with overweight in 28.4% of cases and obesity in 19.7% of cases. Erectile dysfunction affected 91.2% of the study population. The mean IIEF5 score was 11±3, with 22.8% mild degree dysfunction, 55.7% moderate, and 20.3% dysfunction considered severe. The hormonal profile showed mean testosterone levels =4.02±1.53 ng/ml with a decreased levels in 61.1% of cases.

Conclusions: In addition to the high prevalence of erectile dysfunction in diabetics, this study also shows that it is important to rate the degree of severity of the dysfunction to better match the treatment. This is why erectile difficulties must be systematically detected at least annually, in the same way as another complication.